IL6 and infection: In the mouse infection model, Ply5218 repeated dosing (6, 24, and 48 h post-infection) not only alleviated the clinical symptoms caused by Streptococcus in piglets, but also significantly reduced the bacterial loads and the level of interleukin-6 (IL-6) (Wang et al., 2019).